Matson, Inc. (MATX) officer Peter T. Heilmann has filed a notice under Rule 144 to sell up to 5,000 shares of Matson common stock through Fidelity Brokerage Services LLC on the NYSE. The shares derive from restricted stock vesting awards granted as compensation on several dates from 2017 and 2023.
Matson, Inc. (MATX) is the issuer for a planned sale of common stock by company officer Christopher A. Scott under Rule 144. A notice has been filed to sell 600 shares of Matson common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $131,940.05 and Matson common shares outstanding of 29,903,458 as of the filing data line. The 600 shares to be sold were acquired from the issuer on 01/27/2024 via restricted stock vesting as compensation. The notice also reports that 1,520 shares of Matson common stock were sold in the past three months for aggregate proceeds of $275,196.00.
Matson, Inc. Senior Vice President Jason Lee Taylor reported a sale of 1,961 shares of common stock on 2026-08-13 at $217.00 per share in an open market or private transaction. Following this sale, Taylor directly holds 9,377 shares of Matson common stock.
A group of American Century entities, including American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research, reports beneficial ownership of Matson, Inc. common stock. American Century ETF Trust holds 1,676,889 shares with sole voting and dispositive power, representing 5.5% of the outstanding common stock. The other American Century entities and Stowers Institute report beneficial ownership of 1,760,017 shares, representing 5.8% of the class, all with sole voting and dispositive power and no shared power.
The securities are held on behalf of various investment companies and institutional accounts advised by American Century Investment Management, Inc., and no single client advised by it owns more than 5% of the class.
Matson, Inc. (MATX) has a planned sale of restricted common stock under Rule 144. Jason Taylor has filed to potentially sell 1,961 shares of common stock through Fidelity Brokerage Services LLC on or after August 13, 2026, with an indicated aggregate market value of $425,537.00. The filing states that 29,903,458 common shares are outstanding. It also lists prior compensation-related restricted stock vesting events in 2024 and 2025 and notes that Taylor sold 1,650 shares of common stock in the past three months for proceeds of $300,696.00.
Matson, Inc. insider John Warren Sullivan, a Senior Vice President, reported a sale of common stock. On 2026-08-11, he sold 1,917 shares at a price of $208.49 per share in a transaction described as a sale in the open market or a private transaction. Following this sale, he directly holds 7,630 shares of Matson common stock. The filing indicates the Rule 10b5-1 plan checkbox was not selected.
Matson, Inc. senior vice president Jennifer C. Tungul reported a sale of 402 shares of common stock on 2026-08-11 in a transaction classified as a sale in open market or private transaction. The shares were sold at an average price of $208.49 per share, and following the transaction she held 5,852 shares of Matson common stock directly. The Rule 10b5-1 checkbox was left unchecked, so the filing does not state that this sale was made under a trading plan.
Matson, Inc. senior vice president Kuuhaku T Park reported a sale of 1,000 shares of Matson common stock on August 11, 2026, in an open-market or private transaction at $208.49 per share. Following this transaction, Park directly holds 9,984.313 shares of Matson common stock.
Matson, Inc. Senior Vice President Leonard P. Isotoff reported a sale of 1,250 shares of common stock on 2026-08-11 in an open market or private transaction at a weighted average price of $208.2963 per share. Following this transaction, he holds 6,527.132 shares of Matson common stock directly. The sale price reflects multiple trades executed between $208.055 and $209.00 per share.